Corey Robert Tiller, PA

Corey Tiller practices at Kaiser Permanente - Fontana Medical Center in Fontana, California.

Corey Tiller's NPI, 1982122776, was assigned on September 1, 2017. Corey Tiller holds California license 54880.

Corey Tiller's primary practice is Kaiser Permanente - Fontana Medical Center, at 9965 Sierra Ave, Fontana, CA 92335 in San Bernardino County. The practice phone is (909) 427-5000.

Corey Tiller's primary practice is Kaiser Permanente - Fontana Medical Center in Fontana, California. The medical group on file is Vituity. Dmand AI also links Corey Tiller to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Corey Tiller practices. Vendor and product names are available with a free account.

Physician assistant is Corey Tiller's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Corey Tiller is licensed in California.

CMS data shows 128 Medicare services from Corey Tiller across 3 procedure codes in 2024, for 111 Medicare patients. Medicare paid $10,529 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Corey Tiller in 2024. The largest group is 65 to 74, with 46 patients. 67% of them have high blood pressure, and 59% have high cholesterol. 82% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Corey Tiller's median patient age at 38, with 57% women.

In 2024, Corey Tiller wrote 334 Medicare Part D claims for 227 patients. 94% of them were for generic drugs. CMS names the drug for 177 of them, across 9 drugs with 11 or more claims each, at $934 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Corey Tiller for performance year 2024, reported as part of a group.

CMS Open Payments shows 1 general payment to Corey Tiller from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Xeris Pharmaceuticals, Inc. paid the most, $17.